Is Comgestfx (CLONE) a Scam?

At FXCanary, our safety assessments are built on a foundation of verifiable, public-record evidence: regulatory licences, corporate registrations, and the broker's own published terms. We do not rely on marketing claims or unaudited website copy, and we treat the absence of independent user reviews as a significant information gap rather than a neutral fact. For a broker with no track record and no community feedback, the burden of proof falls entirely on the regulated status and transparency of the entity itself.

In the case of Comgestfx (CLONE), our records show no verified regulatory licence on file, no confirmed country of registration, and no verifiable website or social-media presence beyond the domain listed. These three gaps form the basis of our FXCanary Scam Risk Score of 55/100, which we classify as 'Elevated'. This score is not a verdict of fraud, but a measure of how much independent verification is possible — and here, it is very little. A trader approaching this broker would be doing so without the safety net of a recognised regulator or a verifiable corporate identity.

The most critical finding in our review is the complete absence of a regulatory licence. In the forex industry, a licence from a reputable authority — such as the FCA in the UK, ASIC in Australia, or CySEC in Cyprus — brings with it a set of enforceable obligations: client fund segregation, participation in compensation schemes, and negative balance protection. Without such a licence, none of these protections can be assumed. Our records list zero licences for Comgestfx (CLONE), and we have not been able to identify any regulator that oversees its operations.

This regulatory void has practical consequences. If a client deposits funds with an unlicensed broker, those funds are not protected by any statutory compensation scheme. In the event of a dispute, insolvency, or outright disappearance, the client has no regulatory ombudsman to turn to, and no government-backed fund to reimburse losses. The absence of a licence also means the broker is not subject to regular audits, capital adequacy requirements, or conduct-of-business rules. In FXCanary's assessment, this is the single most important risk factor for any trader considering this entity.

For regulated brokers, client fund protection typically includes three pillars: segregation of client money from the broker's own operational funds, membership in a compensation scheme (such as the FSCS in the UK or the ICF in Cyprus), and negative balance protection that prevents a trader from owing more than their account balance. Each of these is a contractual and regulatory commitment that can be verified through public registers. For Comgestfx (CLONE), none of these pillars can be confirmed.

Without segregation, there is a risk that client deposits are used for the broker's own purposes, which is a common red flag in unregulated operations. Without a compensation scheme, even a legitimate broker failure could result in total loss of deposited funds. And without negative balance protection, a sharp market move could leave a trader with a debt to the broker. We are not stating that Comgestfx (CLONE) engages in any of these practices — we are stating that the absence of a licence means there is no independent mechanism to prevent or remedy them. For a cautious trader, this is a decisive gap.

The name 'Comgestfx' itself carries a warning. The suffix 'CLONE' in our records indicates that this entity is either an impersonator of a legitimate brand or a name designed to be confused with an existing financial firm. In the forex industry, clone scams are a well-documented phenomenon: fraudsters register a domain that closely resembles a reputable broker, use similar branding, and then solicit deposits before disappearing. The fact that our records list zero confirmed clone sites for this specific name does not reduce the risk — it simply means we have not yet identified the original entity being mimicked.

We cross-checked the official domain, http://www.comgestfx.com/, against our records and found no verifiable corporate registration or regulatory link. The website itself, as of our review, offers no clear legal entity name, no registered address, and no regulatory disclosures — all of which are standard for legitimate brokers. In the absence of such disclosures, we cannot rule out that this is a clone operation. Traders should be extremely cautious when dealing with any entity that does not clearly state its legal identity and regulatory status on its website.

Our web search for 'Comgestfx' returned results that, on inspection, do not clearly match the entity in our records. The search surfaced references to a different company with a similar name — one that appears to be an asset management firm with a legitimate corporate presence. This is a classic example of the confusion that clone brokers exploit: a trader searching for 'Comgestfx' might find the legitimate firm's website or news mentions and mistakenly assume they are dealing with that entity. We have set our web confidence to 'low' for these results, meaning we do not rely on them to describe the broker under review.

This mismatch is itself a safety finding. It means that any information a trader finds online about 'Comgestfx' may relate to a completely different company, making independent verification even harder. We advise traders to verify the exact domain and regulatory licence of any broker before depositing funds, and to be suspicious if the domain does not match the legal entity name. In this case, the domain comgestfx.com does not correspond to any regulated entity in our records.

As of our review, there are no independent user reviews for Comgestfx (CLONE) on any of the platforms we monitor. This is a double-edged sword. On the one hand, the absence of complaints could suggest that the broker has not yet had time to accumulate negative feedback — but it equally means there is no positive track record to validate its claims. In our experience, legitimate brokers typically accumulate reviews within months of launching, especially if they are actively marketing to retail clients. The complete silence here is unusual and, in our view, a cautionary signal.

We do not interpret the lack of reviews as proof of fraud, but we do treat it as a significant information gap. A trader considering this broker would be making a decision with no independent data points — no one to confirm that withdrawals work, that spreads are as advertised, or that customer support is responsive. In such a situation, the prudent approach is to assume the worst until proven otherwise. FXCanary's role is to flag this uncertainty, not to fill it with speculation.

If you are still considering an entity like Comgestfx (CLONE), we recommend a series of concrete checks before any deposit. First, verify the broker's legal entity name and registration number in the official register of its claimed country of incorporation — if no country is disclosed, treat that as a red flag. Second, confirm the regulatory licence directly on the regulator's website, not on the broker's site, and check that the licence number matches the entity you are dealing with. Third, test the withdrawal process with a small amount before committing larger funds, and be wary of any pressure to deposit more.

Fourth, search for the exact domain name and the broker's name in quotes, and look for any warnings from financial regulators or industry watchdogs. Fifth, check whether the broker is listed on any public warning lists, such as those maintained by the FCA or ASIC. Finally, consider using a regulated broker that offers segregation, compensation, and negative balance protection as a baseline. In FXCanary's assessment, the risks associated with an unlicensed, unverifiable broker like Comgestfx (CLONE) far outweigh any potential benefits, and we would advise most traders to look elsewhere.

In summary, FXCanary's assessment of Comgestfx (CLONE) is that it presents an elevated risk profile, driven primarily by the complete absence of regulatory oversight and the lack of verifiable corporate information. Our Scam Risk Score of 55/100 reflects this, but it is important to understand what the score does and does not say. It does not say that the broker is definitely a scam — it says that the available evidence is insufficient to establish safety, and that the warning signs are numerous.

We encourage traders to treat this broker with extreme caution and to demand a level of transparency that, so far, it has not provided. Until Comgestfx (CLONE) publishes a verifiable licence, a legal entity name, and a clear regulatory status, we cannot recommend it as a safe counterparty. The absence of independent reviews and the confusion with a similarly named legitimate firm only reinforce our caution. In the world of forex trading, where unregulated entities can disappear overnight, the burden of proof must always lie with the broker — and here, that burden has not been met.